Ms. Rosemary Crane has over 37 years of experience in the healthcare industry, with a strong focus in commercialization and business operations. She has more than 25 years of therapeutic and consumer drug launch experience.
Ms. Crane served as President and Chief Executive Officer of MELA Sciences and was a partner at Appletree Partners. She also served as President and Chief Executive Officer of Epocrates, where she led a very successful IPO. She served in various senior executive positions at Johnson & Johnson, including as Group Chairman, OTC & Nutritional Group, as Group Chairman, Consumer, Specialty Pharmaceuticals and Nutritionals. Prior to that, Ms. Crane managed a $7 billion business as President US Primary Care at Bristol Myers Squibb,
Ms. Crane currently serves on the Board of Directors for Tarsus Pharmaceuticals (Nasdaq: TARS), Catalent Pharma Solutions (NYSE: CTLT) and Teva Pharmaceuticals (NYSE: TEVA). She is also the Vice Chairman of the Foundation Board at State University of New York at Oswego.